Sotera Health (NASDAQ:SHC) Sees Strong Trading Volume – Should You Buy?

Shares of Sotera Health (NASDAQ:SHC) saw unusually-strong trading volume on Tuesday . Approximately 1,561,190 shares changed hands during mid-day trading, an increase of 33% from the previous session’s volume of 1,171,206 shares.The stock last traded at $11.36 and had previously closed at $11.66.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th. The Goldman Sachs Group initiated coverage on Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Sotera Health Stock Up 0.3 %

The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock has a 50-day simple moving average of $12.73 and a two-hundred day simple moving average of $13.89. The firm has a market cap of $3.16 billion, a PE ratio of 45.02 and a beta of 1.92.

Institutional Trading of Sotera Health

A number of institutional investors have recently made changes to their positions in SHC. Blue Trust Inc. grew its holdings in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the last quarter. Quarry LP bought a new stake in shares of Sotera Health in the fourth quarter worth about $28,000. GAMMA Investing LLC increased its holdings in Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after purchasing an additional 1,121 shares during the period. Tower Research Capital LLC TRC raised its position in Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after purchasing an additional 1,640 shares during the last quarter. Finally, Sterling Capital Management LLC grew its position in shares of Sotera Health by 58.5% in the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock worth $124,000 after buying an additional 3,331 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.